These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34020616)

  • 1. Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country.
    Sullivan K; Pease C; Zwerling A; Mallick R; Van Dyk D; Mulpuru S; Allen C; Alsdurf H; Alvarez GG
    BMC Public Health; 2021 May; 21(1):964. PubMed ID: 34020616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction of short course treatment for latent tuberculosis infection at a primary care facility for refugees in Winnipeg, Canada: A mixed methods evaluation.
    Chevrier C; Diaz MH; Rueda ZV; Balakumar S; Haworth-Brockman M; Marin DM; Oliver A; Plourde P; Keynan Y
    Front Public Health; 2022; 10():1064136. PubMed ID: 36726628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher Completion Rates With Self-administered Once-weekly Isoniazid-rifapentine Versus Daily Rifampin in Adults With Latent Tuberculosis.
    Haas MK; Aiona K; Erlandson KM; Belknap RW
    Clin Infect Dis; 2021 Nov; 73(9):e3459-e3467. PubMed ID: 32915203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The latent tuberculosis infection cascade of care in Iqaluit, Nunavut, 2012-2016.
    Pease C; Zwerling A; Mallick R; Patterson M; Demaio P; Finn S; Allen J; Van Dyk D; Alvarez GG
    BMC Infect Dis; 2019 Oct; 19(1):890. PubMed ID: 31651260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved treatment completion with shorter treatment regimens for latent tuberculous infection.
    Macaraig MM; Jalees M; Lam C; Burzynski J
    Int J Tuberc Lung Dis; 2018 Nov; 22(11):1344-1349. PubMed ID: 30355415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
    Li J; Munsiff SS; Tarantino T; Dorsinville M
    Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic.
    Gaensbauer J; Aiona K; Haas M; Reves R; Young J; Belknap R
    Pediatr Infect Dis J; 2018 Mar; 37(3):224-228. PubMed ID: 28777204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent Tuberculosis Cascade of Care Among Healthcare Workers: A Nationwide Cohort Analysis in Korea Between 2017 and 2018.
    Min J; Kim HW; Choi JY; Shin AY; Kang JY; Lee Y; Myong JP; Jeong H; Bae S; Koo HK; Lee SS; Park JS; Yim HW; Kim JS
    J Korean Med Sci; 2022 May; 37(20):e164. PubMed ID: 35607742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study.
    Schein YL; Madebo T; Andersen HE; Arnesen TM; Dyrhol-Riise AM; Tveiten H; White RA; Winje BA
    BMC Infect Dis; 2018 Nov; 18(1):587. PubMed ID: 30453946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with isoniazid or rifampin for latent tuberculosis infection: population-based study of hepatotoxicity, completion and costs.
    Ronald LA; FitzGerald JM; Bartlett-Esquilant G; Schwartzman K; Benedetti A; Boivin JF; Menzies D
    Eur Respir J; 2020 Mar; 55(3):. PubMed ID: 31980498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of 3 months of weekly rifapentine and isoniazid compared with other standard treatment regimens for latent tuberculosis infection: a decision analysis study.
    Doan TN; Fox GJ; Meehan MT; Scott N; Ragonnet R; Viney K; Trauer JM; McBryde ES
    J Antimicrob Chemother; 2019 Jan; 74(1):218-227. PubMed ID: 30295760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Status of Latent Tuberculosis Infection Treatment Among Pediatric Patients in Korea: Prescription and Treatment Completion.
    Kim Y; Bae KS; Choi UY; Han SB; Kim JH
    J Korean Med Sci; 2024 Feb; 39(7):e64. PubMed ID: 38412611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of treatment completion for latent tuberculosis infection with 4 months of rifampin.
    Lardizabal A; Passannante M; Kojakali F; Hayden C; Reichman LB
    Chest; 2006 Dec; 130(6):1712-7. PubMed ID: 17166986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of losses in the latent tuberculosis cascade of care in Brazil: A retrospective cohort study.
    Araújo NCN; Cruz CMS; Arriaga MB; Cubillos-Angulo JM; Rocha MS; Silveira-Mattos PS; Matos GM; Marques IMB; Espirito Santo ICP; Almeida LL; Andrade CM; Souza LA; Netto EM; Andrade BB
    Int J Infect Dis; 2020 Apr; 93():277-283. PubMed ID: 32081776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic.
    Rennert-May E; Hansen E; Zadeh T; Krinke V; Houston S; Cooper R
    Can Respir J; 2016; 2016():7980869. PubMed ID: 27445565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    Bastos ML; Melnychuk L; Campbell JR; Oxlade O; Menzies D
    PLoS Med; 2021 Sep; 18(9):e1003703. PubMed ID: 34492003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of Latent Tuberculosis Treatment Acceptance and Completion in Healthcare Personnel.
    Swift MD; Molella RG; Vaughn AIS; Breeher LE; Newcomb RD; Abdellatif S; Murad MH
    Clin Infect Dis; 2020 Jul; 71(2):284-290. PubMed ID: 31552416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of 3 months of weekly rifapentine and isoniazid compared to isoniazid monotherapy in a Canadian arctic setting.
    Pease C; Alvarez G; Mallick R; Patterson M; Finn S; Habis Y; Schwartzman K; Kilabuk E; Mulpuru S; Zwerling A
    BMJ Open; 2021 May; 11(5):e047514. PubMed ID: 33986067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Completion of treatment for latent tuberculosis infection with monthly drug dispensation directly through the tuberculosis clinic.
    Dobler CC; Marks GB
    PLoS One; 2012; 7(11):e48900. PubMed ID: 23139824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmatic Effectiveness of Latent Tuberculosis Care Cascade in a Community Health Center.
    Prater C; Holzman S; Shah M
    J Immigr Minor Health; 2021 Jun; 23(3):566-573. PubMed ID: 32705451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.